CORCYM Mitral, Aortic aNd Tricuspid Post-maRket Study in a reAl-world Setting (MANTRA)
Sponsor: Corcym S.r.l
A observational or N/A phase clinical study on Cardiac Valve Disease, this trial is actively recruiting participants. The trial is conducted by Corcym S.r.l and has accumulated 18 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
18 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Recruiting
-
Mar 2024 — Apr 2024 [monthly]
Recruiting
▶ Show 13 earlier versions
-
Jan 2024 — Mar 2024 [monthly]
Recruiting
-
Sep 2023 — Jan 2024 [monthly]
Recruiting
-
Jun 2023 — Sep 2023 [monthly]
Recruiting
-
Apr 2023 — Jun 2023 [monthly]
Recruiting
-
Mar 2023 — Apr 2023 [monthly]
Recruiting
-
Dec 2022 — Mar 2023 [monthly]
Recruiting
-
Nov 2022 — Dec 2022 [monthly]
Recruiting
-
Sep 2022 — Nov 2022 [monthly]
Recruiting
-
Jun 2022 — Sep 2022 [monthly]
Recruiting
-
Apr 2022 — Jun 2022 [monthly]
Recruiting
-
Feb 2022 — Apr 2022 [monthly]
Recruiting
-
Jan 2022 — Feb 2022 [monthly]
Recruiting
-
Sep 2021 — Jan 2022 [monthly]
Recruiting
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Corcym S.r.l
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ancona, Italy , Augsburg, Germany , Bad Nauheim, Germany , Belgrade, Serbia , Berlin, Germany , Bern, Switzerland , Birmingham, United Kingdom , Bologna, Italy , Brescia, Italy , Bristol, United Kingdom and 40 more locations